PillRx only · Injection, Solution, Concentrate · Intravenous
Oxaliplatin
Oxaliplatin
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
419
Rx · 2026 Q1
10K
Units dispensed
-65%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Accord Healthcare Inc. | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Hospira, Inc. | unknown | 2 | SUPPLYING |
| Winthrop U.S, a business of sanofi-aventis U.S. LLC | unknown | 2 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 0 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 25, 2026RESOLVEDShortage resolved: Oxaliplatin Injection (Fresenius Kabi USA, LLC)
Oxaliplatin Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.
- Feb 25, 2026SHORTAGEDrug shortage: Oxaliplatin Injection (Fresenius Kabi USA, LLC)
Oxaliplatin Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Oncology.